Literature DB >> 27266992

Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research.

Spencer Bujarski1, Lara A Ray2.   

Abstract

In spite of high prevalence and disease burden, scientific consensus on the etiology and treatment of Alcohol Use Disorder (AUD) has yet to be reached. The development and utilization of experimental psychopathology paradigms in the human laboratory represents a cornerstone of AUD research. In this review, we describe and critically evaluate the major experimental psychopathology paradigms developed for AUD, with an emphasis on their implications, strengths, weaknesses, and methodological considerations. Specifically we review alcohol administration, self-administration, cue-reactivity, and stress-reactivity paradigms. We also provide an introduction to the application of experimental psychopathology methods to translational research including genetics, neuroimaging, pharmacological and behavioral treatment development, and translational science. Through refining and manipulating key phenotypes of interest, these experimental paradigms have the potential to elucidate AUD etiological factors, improve the efficiency of treatment developments, and refine treatment targets thus advancing precision medicine.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol administration; Alcohol use disorder; Cue-reactivity; Experimental psychopathology; Self-administration; Stress

Mesh:

Year:  2016        PMID: 27266992      PMCID: PMC5067182          DOI: 10.1016/j.brat.2016.05.008

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  183 in total

1.  Meta-analysis of cue-reactivity in addiction research.

Authors:  B L Carter; S T Tiffany
Journal:  Addiction       Date:  1999-03       Impact factor: 6.526

Review 2.  Incentive-sensitization and addiction.

Authors:  T E Robinson; K C Berridge
Journal:  Addiction       Date:  2001-01       Impact factor: 6.526

3.  DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues.

Authors:  F Joseph McClernon; Kent E Hutchison; Jed E Rose; Rachel V Kozink
Journal:  Psychopharmacology (Berl)       Date:  2007-07-05       Impact factor: 4.530

4.  Alcohol consumption, ACTH level, and family history of alcoholism.

Authors:  M A Schuckit; S C Risch; E O Gold
Journal:  Am J Psychiatry       Date:  1988-11       Impact factor: 18.112

5.  Assessing individual differences in ethanol preference using a cumulative dosing procedure.

Authors:  H DeWit; J Pierri; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Predicting the future relapse of alcohol-dependent patients from structural and functional brain images.

Authors:  Sambu Seo; Johannes Mohr; Anne Beck; Torsten Wüstenberg; Andreas Heinz; Klaus Obermayer
Journal:  Addict Biol       Date:  2015-10-04       Impact factor: 4.280

7.  Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Authors:  Lara A Ray; Kent E Hutchison
Journal:  Arch Gen Psychiatry       Date:  2007-09

8.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  Development and pilot validation of computer-assisted self-infusion of ethanol (CASE): a new method to study alcohol self-administration in humans.

Authors:  Ulrich S Zimmermann; Inge Mick; Victor Vitvitskyi; Martin H Plawecki; Karl F Mann; Sean O'Connor
Journal:  Alcohol Clin Exp Res       Date:  2008-07       Impact factor: 3.455

10.  The incentive salience of alcohol: translating the effects of genetic variant in CNR1.

Authors:  Kent E Hutchison; Heather Haughey; Michelle Niculescu; Joe Schacht; Alan Kaiser; Jerry Stitzel; William J Horton; Francesca Filbey
Journal:  Arch Gen Psychiatry       Date:  2008-07
View more
  11 in total

1.  Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis.

Authors:  Lara A Ray; ReJoyce Green; Daniel J O Roche; Molly Magill; Spencer Bujarski
Journal:  Addict Biol       Date:  2019-05-30       Impact factor: 4.280

2.  A Review of Developmental Considerations in Human Laboratory Alcohol Research.

Authors:  Christian S Hendershot; Christina N Nona
Journal:  Curr Addict Rep       Date:  2017-09-30

3.  Moderators of subjective response to alcohol in the human laboratory.

Authors:  Steven J Nieto; Erica N Grodin; Diana Ho; Wave-Ananda Baskerville; Lara A Ray
Journal:  Alcohol Clin Exp Res       Date:  2022-02-11       Impact factor: 3.928

Review 4.  Overcoming the "Valley of Death" in Medications Development for Alcohol Use Disorder.

Authors:  Lara A Ray; Spencer Bujarski; Daniel James Olan Roche; Molly Magill
Journal:  Alcohol Clin Exp Res       Date:  2018-07-30       Impact factor: 3.455

5.  Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial.

Authors:  Lara A Ray; Spencer Bujarski; Steve Shoptaw; Daniel Jo Roche; Keith Heinzerling; Karen Miotto
Journal:  Neuropsychopharmacology       Date:  2017-01-16       Impact factor: 8.294

6.  The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self-Administration in the Human Laboratory.

Authors:  ReJoyce Green; Erica Grodin; Aaron C Lim; Alexandra Venegas; Spencer Bujarski; Jennifer Krull; Lara A Ray
Journal:  Alcohol Clin Exp Res       Date:  2019-04-12       Impact factor: 3.928

7.  Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder.

Authors:  Lara A Ray; Han Du; ReJoyce Green; Daniel J O Roche; Spencer Bujarski
Journal:  Neuropsychopharmacology       Date:  2020-11-24       Impact factor: 8.294

8.  A novel human laboratory model for screening medications for alcohol use disorder.

Authors:  Diana Ho; Brandon Towns; Erica N Grodin; Lara A Ray
Journal:  Trials       Date:  2020-11-23       Impact factor: 2.279

Review 9.  A meta-regression of methodological features that predict the effects of medications on the subjective response to alcohol.

Authors:  ReJoyce Green; Han Du; Erica N Grodin; Steven J Nieto; Spencer Bujarski; Daniel J O Roche; Lara A Ray
Journal:  Alcohol Clin Exp Res       Date:  2021-07-05       Impact factor: 3.928

Review 10.  Immune treatments for alcohol use disorder: A translational framework.

Authors:  Lindsay R Meredith; Elizabeth M Burnette; Erica N Grodin; Michael R Irwin; Lara A Ray
Journal:  Brain Behav Immun       Date:  2021-07-31       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.